Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2021 - 03 - 22 crawled time : 07:00 save search
Xenetic Biosciences Announces Ticker Symbol Change to XBIO
Published: 2014-02-14 (Crawled : 07:00) - globenewswire.com
BAX | $40.4 2.36% 0.0% 3.2M
|
Health Technology
| Email alert
Add to watchlist
XBIO | $4.2 7.32% 7.2K
|
Health Technology
| Email alert
Add to watchlist
bioscience
Xenetic Biosciences Announces Opening of Corporate Headquarters and R&D Facility in Lexington, MA
Published: 2014-03-04 (Crawled : 07:00) - globenewswire.com
BAX | $40.4 2.36% 0.0% 3.2M
|
Health Technology
| Email alert
Add to watchlist
XBIO | $4.2 7.32% 7.2K
|
Health Technology
| Email alert
Add to watchlist
bioscience
Xenetic Biosciences Appoints Darlene Deptula-Hicks to Board of Directors
Published: 2014-04-04 (Crawled : 07:00) - globenewswire.com
ICAD | $1.47 -4.55% -4.76% 190K
|
Technology Services
| Email alert
Add to watchlist
BAX | $40.4 2.36% 0.0% 3.2M
|
Health Technology
| Email alert
Add to watchlist
XBIO | $4.2 7.32% 7.2K
|
Health Technology
| Email alert
Add to watchlist
ABMD | $381.02 0.06% 0.07%
|
Health Technology
| Email alert
Add to watchlist
bioscience
Xenetic Biosciences Announces Positive Phase 1 Clinical Data for PulmoXen(TM) for Treatment of Cystic Fibrosis
Published: 2014-04-07 (Crawled : 07:00) - globenewswire.com
BAX | $40.4 2.36% 0.0% 3.2M
|
Health Technology
| Email alert
Add to watchlist
XBIO | $4.2 7.32% 7.2K
|
Health Technology
| Email alert
Add to watchlist
treatment fibrosis phase 1 positive phase 3 phase 2 cystic fibrosis
Xenetic Biosciences Announces Full Year 2013 Financial Results and Business Update
Published: 2014-04-16 (Crawled : 07:00) - globenewswire.com
XBIO | $4.2 7.32% 7.2K
|
Health Technology
| Email alert
Add to watchlist
financial results results bioscience
Xenetic Biosciences Appoints Industry Veteran Mark Leuchtenberger as Chairman of the Board of Directors
Published: 2014-05-05 (Crawled : 07:00) - globenewswire.com
XBIO | $4.2 7.32% 7.2K
|
Health Technology
| Email alert
Add to watchlist
bioscience
Novartis appoints Karen Hale as Chief Legal Officer
Published: 2021-03-22 (Crawled : 07:00) - globenewswire.com
NVS | News | $95.12 0.81% -1.18% 2.4M
|
Health Technology
|
| O: -0.49%
H: 1.34%
C: 1.16%
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.